
The global Surgical Site Infection Prevention and Control Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
SSIs are potential complications associated with any type of surgical procedure. Although SSIs are among the most preventable HAIs, they still represent a significant burden in terms of patient morbidity and mortality and additional costs to health systems and service payers worldwide. SSI is both the most frequently studied and the leading HAI reported hospital-wide in LMICs. For these reasons, the prevention of SSI has received considerable attention from surgeons and infection control professionals, health care authorities, the media and the public. In particular, there is a perception among the public that SSIs may reflect a poor quality of care.
Many factors influence surgical wound healing and determine the potential for infection. These include patient-related (endogenous) and process/procedural-related (exogenous) variables that affect a patientās risk of developing an SSI. Some variables are obviously not modifiable, such as age and gender. However, other potential factors can be improved to increase the likelihood of a positive surgical outcome, such as nutritional status, tobacco use, correct use of antibiotics and the intraoperative technique.
In ASEAN market, key players of surgical site infection prevention and control devices include 3M Company, Cardinal Health, Inc., B. Braun Melsungen AG and ME Medical, etc.
In terms of type, skin preparation is most popular and has a market share of about 60%, followed by hair removal devices and wound rinse. In terms of application, oncology is the dominant field using surgical site infection prevention and control devices. Other application include orthopaedic, general surgery and paediatric surgery.
The āSurgical Site Infection Prevention and Control Devices Industry Forecastā looks at past sales and reviews total world Surgical Site Infection Prevention and Control Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Surgical Site Infection Prevention and Control Devices sales for 2025 through 2031. With Surgical Site Infection Prevention and Control Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Surgical Site Infection Prevention and Control Devices industry.
This Insight Report provides a comprehensive analysis of the global Surgical Site Infection Prevention and Control Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Surgical Site Infection Prevention and Control Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firmsā unique position in an accelerating global Surgical Site Infection Prevention and Control Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Surgical Site Infection Prevention and Control Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Surgical Site Infection Prevention and Control Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Surgical Site Infection Prevention and Control Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Hair Removal Devices
Skin Preparation
Wound Rinse
Segmentation by Application:
Oncology
Orthopaedic
General Surgery
Paediatric Surgery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
3M Company
Cardinal Health, Inc.
B. Braun Melsungen AG
ME Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Surgical Site Infection Prevention and Control Devices market?
What factors are driving Surgical Site Infection Prevention and Control Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Surgical Site Infection Prevention and Control Devices market opportunities vary by end market size?
How does Surgical Site Infection Prevention and Control Devices break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Surgical Site Infection Prevention and Control Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Surgical Site Infection Prevention and Control Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Surgical Site Infection Prevention and Control Devices by Country/Region, 2020, 2024 & 2031
2.2 Surgical Site Infection Prevention and Control Devices Segment by Type
2.2.1 Hair Removal Devices
2.2.2 Skin Preparation
2.2.3 Wound Rinse
2.3 Surgical Site Infection Prevention and Control Devices Sales by Type
2.3.1 Global Surgical Site Infection Prevention and Control Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Surgical Site Infection Prevention and Control Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Surgical Site Infection Prevention and Control Devices Sale Price by Type (2020-2025)
2.4 Surgical Site Infection Prevention and Control Devices Segment by Application
2.4.1 Oncology
2.4.2 Orthopaedic
2.4.3 General Surgery
2.4.4 Paediatric Surgery
2.5 Surgical Site Infection Prevention and Control Devices Sales by Application
2.5.1 Global Surgical Site Infection Prevention and Control Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Surgical Site Infection Prevention and Control Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Surgical Site Infection Prevention and Control Devices Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Surgical Site Infection Prevention and Control Devices Breakdown Data by Company
3.1.1 Global Surgical Site Infection Prevention and Control Devices Annual Sales by Company (2020-2025)
3.1.2 Global Surgical Site Infection Prevention and Control Devices Sales Market Share by Company (2020-2025)
3.2 Global Surgical Site Infection Prevention and Control Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Surgical Site Infection Prevention and Control Devices Revenue by Company (2020-2025)
3.2.2 Global Surgical Site Infection Prevention and Control Devices Revenue Market Share by Company (2020-2025)
3.3 Global Surgical Site Infection Prevention and Control Devices Sale Price by Company
3.4 Key Manufacturers Surgical Site Infection Prevention and Control Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Surgical Site Infection Prevention and Control Devices Product Location Distribution
3.4.2 Players Surgical Site Infection Prevention and Control Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Surgical Site Infection Prevention and Control Devices by Geographic Region
4.1 World Historic Surgical Site Infection Prevention and Control Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Surgical Site Infection Prevention and Control Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Surgical Site Infection Prevention and Control Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Surgical Site Infection Prevention and Control Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Surgical Site Infection Prevention and Control Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Surgical Site Infection Prevention and Control Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Surgical Site Infection Prevention and Control Devices Sales Growth
4.4 APAC Surgical Site Infection Prevention and Control Devices Sales Growth
4.5 Europe Surgical Site Infection Prevention and Control Devices Sales Growth
4.6 Middle East & Africa Surgical Site Infection Prevention and Control Devices Sales Growth
5 Americas
5.1 Americas Surgical Site Infection Prevention and Control Devices Sales by Country
5.1.1 Americas Surgical Site Infection Prevention and Control Devices Sales by Country (2020-2025)
5.1.2 Americas Surgical Site Infection Prevention and Control Devices Revenue by Country (2020-2025)
5.2 Americas Surgical Site Infection Prevention and Control Devices Sales by Type (2020-2025)
5.3 Americas Surgical Site Infection Prevention and Control Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Surgical Site Infection Prevention and Control Devices Sales by Region
6.1.1 APAC Surgical Site Infection Prevention and Control Devices Sales by Region (2020-2025)
6.1.2 APAC Surgical Site Infection Prevention and Control Devices Revenue by Region (2020-2025)
6.2 APAC Surgical Site Infection Prevention and Control Devices Sales by Type (2020-2025)
6.3 APAC Surgical Site Infection Prevention and Control Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Surgical Site Infection Prevention and Control Devices by Country
7.1.1 Europe Surgical Site Infection Prevention and Control Devices Sales by Country (2020-2025)
7.1.2 Europe Surgical Site Infection Prevention and Control Devices Revenue by Country (2020-2025)
7.2 Europe Surgical Site Infection Prevention and Control Devices Sales by Type (2020-2025)
7.3 Europe Surgical Site Infection Prevention and Control Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Surgical Site Infection Prevention and Control Devices by Country
8.1.1 Middle East & Africa Surgical Site Infection Prevention and Control Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Surgical Site Infection Prevention and Control Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Surgical Site Infection Prevention and Control Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Surgical Site Infection Prevention and Control Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Surgical Site Infection Prevention and Control Devices
10.3 Manufacturing Process Analysis of Surgical Site Infection Prevention and Control Devices
10.4 Industry Chain Structure of Surgical Site Infection Prevention and Control Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Surgical Site Infection Prevention and Control Devices Distributors
11.3 Surgical Site Infection Prevention and Control Devices Customer
12 World Forecast Review for Surgical Site Infection Prevention and Control Devices by Geographic Region
12.1 Global Surgical Site Infection Prevention and Control Devices Market Size Forecast by Region
12.1.1 Global Surgical Site Infection Prevention and Control Devices Forecast by Region (2026-2031)
12.1.2 Global Surgical Site Infection Prevention and Control Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Surgical Site Infection Prevention and Control Devices Forecast by Type (2026-2031)
12.7 Global Surgical Site Infection Prevention and Control Devices Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 3M Company
13.1.1 3M Company Company Information
13.1.2 3M Company Surgical Site Infection Prevention and Control Devices Product Portfolios and Specifications
13.1.3 3M Company Surgical Site Infection Prevention and Control Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 3M Company Main Business Overview
13.1.5 3M Company Latest Developments
13.2 Cardinal Health, Inc.
13.2.1 Cardinal Health, Inc. Company Information
13.2.2 Cardinal Health, Inc. Surgical Site Infection Prevention and Control Devices Product Portfolios and Specifications
13.2.3 Cardinal Health, Inc. Surgical Site Infection Prevention and Control Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Cardinal Health, Inc. Main Business Overview
13.2.5 Cardinal Health, Inc. Latest Developments
13.3 B. Braun Melsungen AG
13.3.1 B. Braun Melsungen AG Company Information
13.3.2 B. Braun Melsungen AG Surgical Site Infection Prevention and Control Devices Product Portfolios and Specifications
13.3.3 B. Braun Melsungen AG Surgical Site Infection Prevention and Control Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 B. Braun Melsungen AG Main Business Overview
13.3.5 B. Braun Melsungen AG Latest Developments
13.4 ME Medical
13.4.1 ME Medical Company Information
13.4.2 ME Medical Surgical Site Infection Prevention and Control Devices Product Portfolios and Specifications
13.4.3 ME Medical Surgical Site Infection Prevention and Control Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ME Medical Main Business Overview
13.4.5 ME Medical Latest Developments
14 Research Findings and Conclusion
Ģż
Ģż
*If Applicable.
